Novozymes A/S (OTCMKTS:NVZMY) Shares Pass Below 200-Day Moving Average – What’s Next?

Novozymes A/S (OTCMKTS:NVZMY) passed below its 200-day moving average during trading on Friday . The stock has a 200-day moving average of $62.47 and traded as low as $55.71. Novozymes A/S shares last traded at $55.74, with a volume of 17,179 shares traded.

Analyst Ratings Changes

NVZMY has been the topic of a number of analyst reports. Citigroup cut Novozymes A/S from a “neutral” rating to a “sell” rating in a research note on Thursday, October 17th. Barclays raised Novozymes A/S to a “strong-buy” rating in a report on Monday, November 18th.

Novozymes A/S Trading Down 2.3 %

The firm has a market capitalization of $26.10 billion, a P/E ratio of 35.28, a P/E/G ratio of 3.87 and a beta of 0.87. The firm has a 50-day moving average of $57.21 and a two-hundred day moving average of $62.48.

About Novozymes A/S

Novozymes A/S produces and sells industrial enzymes, microorganisms, and probiotics in Denmark, rest of Europe, North America, Asia Pacific, the Middle East, Africa, Latin America, and internationally. The company offers protein solutions for the food and beverage industry. It also offers industrial hygiene, drain openers, hard surface, medical cleaning, septic tanks, ware washing, and professional laundry services.